健脾疏肝饮治疗糖尿病胃轻瘫的疗效观察
|
摘要
目的:通过临床病例观察和动物实验研究健脾疏肝饮治疗糖尿病胃轻瘫(Diabetic Gastro Paresis.DGP)的疗效。方法:1.临床观察:将60例DGP患者随机分为试验组与对照组各30例。在基础治疗前提下,试验组给予疏肝健脾饮汤剂(基本方为:柴胡,白芍,枳实,党参,黄芪,白术,姜半夏,黄连,生姜,厚朴,木香,当归,炙甘草。)口服;对照组予吗丁啉口服。以临床症状积分、空腹和餐后2h血糖以及糖化血红蛋白等为评价标准,通过与对照组的比较讨论疗效。2.动物实验:建立糖尿病胃轻瘫大鼠动物模型,给予中药或生理盐水灌胃8周后,通过模型组,中药组和正常组的阳性神经免疫组化染色比较,讨论健脾疏肝饮的疗效。结果:1.临床观察:治疗组总有效率为93.3%,对照组总有效率为76.7%。两组在治疗后症状总积分上有显著差异(P<0.01),单独症状积分比较显示:两组在治疗早饱、胃脘胀满、嘈杂、纳呆的疗效相当(P>0.05)。而治疗组对DGP患者嗳气、倦怠乏力、恶心、情志不舒等的疗效较对照组有优势(P<0.05)。2.动物实验:8周后大鼠胃窦肌间神经丛中nNOS、5-HT4R染色阳性神经平均灰度值,中药组与模型组、熟地组有显著差异(P<0.01);而它们与正常组比较无明显差异(P> 0.05);表明健脾疏肝饮可对糖尿病大鼠胃窦肌间神经丛有保护作用。结论:疏肝健脾饮在治疗糖尿病胃轻瘫方面有良好的疗效,有临床应用前景。
Objective:To observe the therapeutic effect of traditional Chinese medicine on diabetic gastroparesis。Methods : Clinical research : 60 patients with diabetic grastroparesis were randomly divided into two groups.30 patients in experimental group were treated by traditional Chinese medicine;30 patients in control group were treated by single western medicine,with a treatment course of eight weeks for both groups.The therapeutic effects were evaluated after 1 treatment course.Animal Experiment:building animal models of diabetic gastro paresis,to abserve difference of nNOS、5-HT4R between the Normal group and treated group.Results:Clinical research:There was a significant difference in improvement of symptoms,and in the aspect of nausea anorexia eructation and epigastric upset.Animal Experiment: There was a significant difference in the contents of nNOS、5-HT4R of diabetic gastroparesis rats.Conclusion:Treatment of traditional Chinese medicine is effective in treating diabetic gastroparesis.
Objective:To observe the therapeutic effect of traditional Chinese medicine on diabetic gastroparesis。Methods : Clinical research : 60 patients with diabetic grastroparesis were randomly divided into two groups.30 patients in experimental group were treated by traditional Chinese medicine;30 patients in control group were treated by single western medicine,with a treatment course of eight weeks for both groups.The therapeutic effects were evaluated after 1 treatment course.Animal Experiment:building animal models of diabetic gastro paresis,to abserve difference of nNOS、5-HT4R between the Normal group and treated group.Results:Clinical research:There was a significant difference in improvement of symptoms,and in the aspect of nausea anorexia eructation and epigastric upset.Animal Experiment: There was a significant difference in the contents of nNOS、5-HT4R of diabetic gastroparesis rats.Conclusion:Treatment of traditional Chinese medicine is effective in treating diabetic gastroparesis.
引文
[1] Kassander P.AsymPtomatic gastric retention in diabeties (gastro paresis- diabetiorum).Ann Intern Med l958:48:797—812.
[2]齐惠滨,罗金燕,戴信刚,等.糖尿病性胃轻瘫的动力学研究.新消化病学杂志,1997,5(10):661-662
[3]杨文英,曹辉碧。韩锐,等.糖尿病合并胃运动功能障碍.中华内科杂志,1991,30(7):399-401
[4]彭荔薰,周佩,张青萍.糖尿病病人胃排空功能的研究.中国糖尿病杂志,1997,5(3):147—149
[5]张君,李雪春.临床荟萃-2008.23(5).-334-334
[6]罗金燕.糖尿病胃肠运动障碍[J].新医学,2000,31(11):652—653.
[7]中华医学会糖尿病学分.中国2型糖尿病防治指南.中华内分泌代谢杂志,2008,24(2):增录2a-4.
[8]陈国祯,钟学礼,黄铭新.内科学.北京:人民卫生出版社,1984:681.
[9]于君.胃轻瘫.消化道运动学[M].北京:科学技术出版社,1998;(1):1.
[10]王振华.系统性疾病伴胃动力紊乱.胃肠动力学基础与临床[M].北京:科学技术出版社,1999;(1):4.
[11]许国铭,李石,主编.现代消化病学.北京人民军医出版社,1999:688.690.
[12]中华中医药学会发布.糖尿病中医防治指南.第一版.北京:中国中医药出版社,2007:38—42.
[13]中药新药临床研究指导原则.北京:中国医药科技出版社,2002:133.139;366—368
[14]梁幼稚.糖尿病胃轻瘫中医症候及其胃动力学临床研究.广州中医药大学学位论文2001:31.32.
[15]孙瑞元.定量药理学[M].北京:人民卫生出版社,1987:243.
[16] Russell Y,Ridha A Lewea'nee,C.Gastrointestival tract compications of diabetics.Srchlntern Med,1984,144:1251.
[17]李皓旭,秦晓民,鲁彦,等.糖尿病胃轻瘫发病机制[J].胃肠病和肝病学杂志,2003,12(1):88—90.
[18] Chandrasekharan B。Srinivasan S.Diabetes and the en.teric nervous system [J].Neurogastroenterol Motil,2007,19(12):951—960
[19] Furness JB。Li ZS,Young HM。et a1.Nitric oxide synthase in the enteric nervous system of the guinea pig : A quantitative description.Cell Tissue Res,1994,277:139.
[20] Ganumnitz G , Sweet M A , Sengupta A , et a1. Nitrinergic and peptidegic innervations and their inter-relationships in human colon.Neuropeptides,1995,29:1.
[21]李天津,余保平.5-羟色胺3、4受体与胃肠运动及临床意义[J].国外医学·消化系疾病分册,2004,24(6):354-357
[22] Baker DE. Rationale for using ser0tonergic agents to treatirritable bowel syndrome[J].Am J Health Syst Pharm,2005,62(7):700- 71 1.
[23]张亚萍石德红张宽学罗金燕.糖尿病大鼠胃肠功能紊乱时β2-肾上腺素能受体与5-羟色胺受体表达的变化.中华糖尿病杂志-2004.12(4).-297-299
[24] Rayner CK,Su YC,Doran SM,et a1.The stimulation ofantral motility by erythromycin is advenuated by hyperglycemia[J].Am J Gastroenterol,2000,95(9):2 233—2 241.
[25]王雁,张彤彦,张建忠,等.西沙必利对糖尿病胃肠运动功能障碍的影响[J].基础医学与临床,1999,19(6):516—521.
[26] Lust man PJ,An.derson RJ,Freedland KE,et a1.Depression and poor glycemic controla metal ana]ytic review of the literature.Diabetes Care,2000,23934—942.
[27]张盛忠,卢志达,洪明理,等.20例糖尿病的胃粘膜微血管超微结构观察[J].微循环学杂志,2000,10(2):10—12.
[28]孙子林,刘乃丰,孙桂菊,等.糖尿病小鼠血清糖基化终产物水平增高[J].中国糖尿病杂志,2000,8(5):315.
[29]杜章辉.胃复安的不良反应.中华临床医学研究杂志,2005,11(10):1432—1433.
[30]王雁,张彤彦,张建忠,等.西沙必利对糖尿病胃肠运动功能障碍的影响.基础医学与临床,1999,19:516—521.
[31]历代本草药性汇解.新出音管[2002]056号ISBN 7 89998—450—5/R.040
[32]李芳,李建北,张东明.柴胡的药理研究进展.时珍国医国药-2004.15(2).-120-121
[33]谢东浩,蔡宝昌,安益强,李霞,贾晓斌.柴胡皂苷类化学成分及药理作用研究进展.南京中医药大学学报-2007.23(1).-63-65
[34]陈四平张浩李相坤李征军.中药白芍的研究进展.承德医学院学报-2008.25(3).-293-296
[35]郑天珍.枳实、白术对大鼠离体胃各部位平滑肌的作用.甘肃科学学报1998:10(3):65"--67.
[36]朱金照.白术、藿香等中药对胃排空、肠推进影响的实验研究.中国中医基础医学杂志2000;6(1):21----23。
[37]马晓松,樊雪萍,陈忠,等.白术对动物肠胃运动的作用及其机制的探讨.中华消化杂志,1996:16(5):261.
[38]王翠芬,杨德治,魏义全,等.枳实对大鼠胃肠电活动影响的初步研究[J].东南大学学报2001,20(3):153—154.
[39]叶菲,申竹芳,谢明智.中药黄连及其复方对实验动物血糖的[J].中国实验方剂学杂志1999:5(3):23—26.
[40]雷载权.中药学.第l版.上海:上海科学技术出版社,2001:31.
[41]江苏新医学院.中药大辞典(上册).第1版.上海:上海人民出版社.1977;71:655.
[42]张天红,张馨等.潞党参药理实验研究.时珍国医国药-2001.12(6).-488-489
[43]赵衍斌,王嫒,严颖.糖尿病胃轻瘫的研究进展.辽宁医学杂志.2004:18(4):210—211.
[1] Kassander P.Asymptomatic gastric retention in diabeties (gastroparesis-diabetiorum).Ann InternMedl958:48:797—812.
[2]罗金燕.糖尿病胃肠运动障碍[J].新医学,2000,31(11):652—653.
[3]程友忠,唐勇,李峻.糖尿病性胃轻瘫临床研究进展实用医院临床杂-2010.7(2).-135-138
[4]齐惠滨,罗金燕,戴信刚,等.糖尿病性胃轻瘫的动力学研究.新消化病学杂志,1997,5(10):661-662
[5]杨文英,曹辉碧。韩锐,等.糖尿病合并胃运动功能障碍.中华内科杂志,1991,30(7):399-401
[6]彭荔薰,周佩,张青萍.糖尿病病人胃排空功能的研究.中国糖尿病杂志,1997,5(3):147—149
[7]张君,李雪春.临床荟萃-2008.23(5).-334-334
[8]赵焕香.醒脾运脾法治疗糖尿病胃轻瘫79例[J].北京中医,2000:19(4):18-19.
[9]黄福斌,徐兆山.辨证分型治疗糖尿病性胃轻瘫42例.浙江中医杂志.2001.36.(4):144—145
[10]刘志勤,吕蕾.辨证论治糖尿病性胃轻瘫24例.河北中医,2003,25(10):738-739
[11]田宝平,胡滨.中医辨证治疗糖尿病性胃轻瘫48例.辽宁中医杂志,2004:31(9):725—726.
[12]高志扬.糖尿病性胃轻瘫辨治心法.四川中医,2003,21(8):18-19
[13]王新歧.赵进喜治疗糖尿病性胃轻瘫经验.浙江中医杂志,2005,7:280-- 281
[14]唐廷汉.半夏泻心汤治疗糖尿病胃轻瘫5O例.四川中医,2001,19(9):35.
[15]邹世昌.乌梅丸加减治疗糖尿病性胃轻瘫40例.中国中西医结合杂志,2002,22(2):150—151.
[16]郑晓军,戴一娜.升阳益胃汤治疗糖尿病胃轻瘫48例.四川中医,2001,19(7):29—30.
[17]衡先培,黄青松.胜红丸治疗糖尿病性胃轻瘫临床研究.安徽中医学院学报,2001:20(2):13一14.
[18]邵丽黎.四逆健脾导滞汤治疗糖尿病性胃轻瘫30例[J].四川中医,2003,21(6) :26—27.
[19]李翠萍.健脾消滞汤治疗糖尿病胃轻瘫疗效观察[J].广西中医药,2003,26(5):30.
[20]张惠珍.健脾益胃汤治疗糖尿病胃轻瘫38例[J].新疆中医药,1999:17(4):24—25.
[21]冯丽,陈东旭.疏肝养胃汤治疗糖尿病性胃轻瘫印例[J].河北中医,2000:22(10):758.
[22]宋秀江,田德禄,李志红等.益气通降方治疗糖尿病胃轻瘫的临床研究[J].中医药学刊,2003:21(2):273—275.
[23]沈璐,杨明丽,李群等.糖胃康治疗糖尿病胃轻瘫48例.陕西中医,2005:26(9):905—906.
[24]何百科.葛银四磨汤治疗糖尿病性胃轻瘫104例[J].陕西中医函授,2001:19(1):30.
[25]王玲.针刺治疗糖尿病胃轻瘫35例.新中医,2003,35(7):50一51.
[26]成秀梅,姬承武,孙灵娇.辨证针刺治疗糖尿病胃轻瘫36例.中国针灸,2003.23(9)525.
[27]赵红,张轶.针刺治疗糖尿病性胃轻瘫34例临床观察。中国针灸2004,24(3)167一168.
[28]朱红梅.壮医药线点灸配合壮药治疗糖尿病胃轻瘫临床观察[J].四川中医,2002,20(10):72—74
[29]蔡敬宙,潘锦瑶.耳穴贴压治疗糖尿病胃轻瘫疗效观察.辽宁中医杂志,2002,29(6):358
[30] Jebbink HJA.Braenboer BakkermansIMA etal,Diabetologia 1993,36:948-954
[31] Russell Y,Ridha A Lewea'nee,C.Gastrointestival tract compications of diabetics.Srchlntern Med,1984,144:1251.
[32]李皓旭,秦晓民,鲁彦,等.糖尿病胃轻瘫发病机制[J].胃肠病和肝病学杂志,2003,12(1):88—90.
[33] Chandrasekharan B。Srinivasan S.Diabetes and the en.teric nervous system [J].Neurogastroenterol Motil,2007,19(12):951—960
[34] Kawaglshi T , Nishizawa Y , Okuno Y , et a1.Efect ofeisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neumpathy[J].Am J Gastroenterol,1993,88(6):933—938.
[35]陈兴国,郭继强,陈新军,等.糖尿病胃轻瘫患者血清胃泌素升高[J].临床检验杂志,2005,23(5):372
[36]陈建,李君曼。李学会,等.糖尿病胃轻瘫患者的胃排空迟缓与血浆胃肠激素变化相关性探讨.山东医药,1997。37(6):9-10
[37]吴波,郑长青,林连捷,等.糖尿病性胃肠病变患者血浆P物质和胃动素的水平及意义[J].世界华人消化杂志,2003,1l(3):367—368.
[38]王雁,张彤彦,张建忠,等.西沙必利对糖尿病胃肠运动功能障碍的影响[J].基础医学与临床,1999,19(6):516—521.
[39] Rayner CK,Su YC,Doran SM,et a1.The stimulation ofantral motility by erythromycin is advenuated by hyperglycemia[J].Am J Gastroenterol,2000,95(9):2 233—2 241.
[40]张亚萍,张宽学,罗金燕.糖尿病大鼠胃肠道CaM间质细胞结构变化研究[J].中华内科学杂志,2002,41(5):310.
[41]张盛忠,卢志达,洪明理,等.20例糖尿病的胃粘膜微血管超微结构观察[J].微循环学杂志,2000,10(2):10—12.
[42]孙子林,刘乃丰,孙桂菊,等.糖尿病小鼠血清糖基化终产物水平增高[J].中国糖尿病杂志,2000,8(5):315.
[43]张春芳,胡洁,赵文.2型糖尿病患者并幽门螺杆菌感染临床分析.临床内科杂27志,200l,18(5):375—376
[44]赵丽娟.2型糖尿病与幽门螺杆菌感染.北京医学,20O2,24(1):44
[45] Guvener N , Akcan Y , Paksoy I , et a1.Helicobacter pylori associated gastric pathology in patients with type IIdiabetes mellitus and its rdatiomhip with gastric emptying : the Ankara stuay[J].Exp Clin Endoerinol Diabe.tes,l999,107(3):172—176.
[46]张亚萍,高革,张宽学,等.糖尿病胃肠功能紊乱模型肠道超微结构变化的研究[J].临床消化病杂志,2002,14(4):150—152.
[47] Lust man PJ,An.derson RJ,Freedland KE,et a1.Depression and poor glycemic controla metal ana]ytic review of the literature.Diabetes Care,2000,23934—942.
[48]杜章辉.胃复安的不良反应.中华临床医学研究杂志,2005,11(10):1432—1433
[49] David S,Mark K,Vasti B.Domperidone in the management of symp toms of diabetic gastroparesis : eficacy , tolerability , and quality of lifeoutcomes in a muhicenter controlled tria1.Clinical Therapeutics,1998,20(3):438—453
[50]王雁,张彤彦,张建忠,等.西沙必利对糖尿病胃肠运动功能障碍的影响.基础医学与临床,1999,19:516—521.
[51]陈世耀,王吉耀.莫沙必利治疗功能性消化不良的随机双盲对照研究.中华流行病学杂志,2004,25(2):165—168.
[52] Lu G,Sarr MG。Szurszeweki JH.Efect of motilin and Eryth—romyeinon calcium-activated potassium channels in rabbitcolonic myocytes. Gastroenterology,1998,114:748—754
[53]周琳,高方,薛耀明,等.依帕司他对糖尿病性胃轻瘫和自主神经病变的影响.中国新药与临床杂志,2007,26(2):134—137.
[54] Dina E,Rajkamal J,Nell K.Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.Gstrointestinal Endoscopy ,2002,7(55):920—923
[55] Ehsan J , Denis O , Emil N , et a1.Implantable neural electrical stimulator for external control of gastrointestinal motility.Medical Engineering& Physics ,2007.29:238—252.
[56]陆英杰,连至成.糖尿病胃轻瘫治疗现状,实用糖尿病杂志.2005:1(6):49—51.
[57]赵衍斌,王嫒,严颖.糖尿病胃轻瘫的研究进展.辽宁医学杂志.2004:18(4):210—211.
[2]齐惠滨,罗金燕,戴信刚,等.糖尿病性胃轻瘫的动力学研究.新消化病学杂志,1997,5(10):661-662
[3]杨文英,曹辉碧。韩锐,等.糖尿病合并胃运动功能障碍.中华内科杂志,1991,30(7):399-401
[4]彭荔薰,周佩,张青萍.糖尿病病人胃排空功能的研究.中国糖尿病杂志,1997,5(3):147—149
[5]张君,李雪春.临床荟萃-2008.23(5).-334-334
[6]罗金燕.糖尿病胃肠运动障碍[J].新医学,2000,31(11):652—653.
[7]中华医学会糖尿病学分.中国2型糖尿病防治指南.中华内分泌代谢杂志,2008,24(2):增录2a-4.
[8]陈国祯,钟学礼,黄铭新.内科学.北京:人民卫生出版社,1984:681.
[9]于君.胃轻瘫.消化道运动学[M].北京:科学技术出版社,1998;(1):1.
[10]王振华.系统性疾病伴胃动力紊乱.胃肠动力学基础与临床[M].北京:科学技术出版社,1999;(1):4.
[11]许国铭,李石,主编.现代消化病学.北京人民军医出版社,1999:688.690.
[12]中华中医药学会发布.糖尿病中医防治指南.第一版.北京:中国中医药出版社,2007:38—42.
[13]中药新药临床研究指导原则.北京:中国医药科技出版社,2002:133.139;366—368
[14]梁幼稚.糖尿病胃轻瘫中医症候及其胃动力学临床研究.广州中医药大学学位论文2001:31.32.
[15]孙瑞元.定量药理学[M].北京:人民卫生出版社,1987:243.
[16] Russell Y,Ridha A Lewea'nee,C.Gastrointestival tract compications of diabetics.Srchlntern Med,1984,144:1251.
[17]李皓旭,秦晓民,鲁彦,等.糖尿病胃轻瘫发病机制[J].胃肠病和肝病学杂志,2003,12(1):88—90.
[18] Chandrasekharan B。Srinivasan S.Diabetes and the en.teric nervous system [J].Neurogastroenterol Motil,2007,19(12):951—960
[19] Furness JB。Li ZS,Young HM。et a1.Nitric oxide synthase in the enteric nervous system of the guinea pig : A quantitative description.Cell Tissue Res,1994,277:139.
[20] Ganumnitz G , Sweet M A , Sengupta A , et a1. Nitrinergic and peptidegic innervations and their inter-relationships in human colon.Neuropeptides,1995,29:1.
[21]李天津,余保平.5-羟色胺3、4受体与胃肠运动及临床意义[J].国外医学·消化系疾病分册,2004,24(6):354-357
[22] Baker DE. Rationale for using ser0tonergic agents to treatirritable bowel syndrome[J].Am J Health Syst Pharm,2005,62(7):700- 71 1.
[23]张亚萍石德红张宽学罗金燕.糖尿病大鼠胃肠功能紊乱时β2-肾上腺素能受体与5-羟色胺受体表达的变化.中华糖尿病杂志-2004.12(4).-297-299
[24] Rayner CK,Su YC,Doran SM,et a1.The stimulation ofantral motility by erythromycin is advenuated by hyperglycemia[J].Am J Gastroenterol,2000,95(9):2 233—2 241.
[25]王雁,张彤彦,张建忠,等.西沙必利对糖尿病胃肠运动功能障碍的影响[J].基础医学与临床,1999,19(6):516—521.
[26] Lust man PJ,An.derson RJ,Freedland KE,et a1.Depression and poor glycemic controla metal ana]ytic review of the literature.Diabetes Care,2000,23934—942.
[27]张盛忠,卢志达,洪明理,等.20例糖尿病的胃粘膜微血管超微结构观察[J].微循环学杂志,2000,10(2):10—12.
[28]孙子林,刘乃丰,孙桂菊,等.糖尿病小鼠血清糖基化终产物水平增高[J].中国糖尿病杂志,2000,8(5):315.
[29]杜章辉.胃复安的不良反应.中华临床医学研究杂志,2005,11(10):1432—1433.
[30]王雁,张彤彦,张建忠,等.西沙必利对糖尿病胃肠运动功能障碍的影响.基础医学与临床,1999,19:516—521.
[31]历代本草药性汇解.新出音管[2002]056号ISBN 7 89998—450—5/R.040
[32]李芳,李建北,张东明.柴胡的药理研究进展.时珍国医国药-2004.15(2).-120-121
[33]谢东浩,蔡宝昌,安益强,李霞,贾晓斌.柴胡皂苷类化学成分及药理作用研究进展.南京中医药大学学报-2007.23(1).-63-65
[34]陈四平张浩李相坤李征军.中药白芍的研究进展.承德医学院学报-2008.25(3).-293-296
[35]郑天珍.枳实、白术对大鼠离体胃各部位平滑肌的作用.甘肃科学学报1998:10(3):65"--67.
[36]朱金照.白术、藿香等中药对胃排空、肠推进影响的实验研究.中国中医基础医学杂志2000;6(1):21----23。
[37]马晓松,樊雪萍,陈忠,等.白术对动物肠胃运动的作用及其机制的探讨.中华消化杂志,1996:16(5):261.
[38]王翠芬,杨德治,魏义全,等.枳实对大鼠胃肠电活动影响的初步研究[J].东南大学学报2001,20(3):153—154.
[39]叶菲,申竹芳,谢明智.中药黄连及其复方对实验动物血糖的[J].中国实验方剂学杂志1999:5(3):23—26.
[40]雷载权.中药学.第l版.上海:上海科学技术出版社,2001:31.
[41]江苏新医学院.中药大辞典(上册).第1版.上海:上海人民出版社.1977;71:655.
[42]张天红,张馨等.潞党参药理实验研究.时珍国医国药-2001.12(6).-488-489
[43]赵衍斌,王嫒,严颖.糖尿病胃轻瘫的研究进展.辽宁医学杂志.2004:18(4):210—211.
[1] Kassander P.Asymptomatic gastric retention in diabeties (gastroparesis-diabetiorum).Ann InternMedl958:48:797—812.
[2]罗金燕.糖尿病胃肠运动障碍[J].新医学,2000,31(11):652—653.
[3]程友忠,唐勇,李峻.糖尿病性胃轻瘫临床研究进展实用医院临床杂-2010.7(2).-135-138
[4]齐惠滨,罗金燕,戴信刚,等.糖尿病性胃轻瘫的动力学研究.新消化病学杂志,1997,5(10):661-662
[5]杨文英,曹辉碧。韩锐,等.糖尿病合并胃运动功能障碍.中华内科杂志,1991,30(7):399-401
[6]彭荔薰,周佩,张青萍.糖尿病病人胃排空功能的研究.中国糖尿病杂志,1997,5(3):147—149
[7]张君,李雪春.临床荟萃-2008.23(5).-334-334
[8]赵焕香.醒脾运脾法治疗糖尿病胃轻瘫79例[J].北京中医,2000:19(4):18-19.
[9]黄福斌,徐兆山.辨证分型治疗糖尿病性胃轻瘫42例.浙江中医杂志.2001.36.(4):144—145
[10]刘志勤,吕蕾.辨证论治糖尿病性胃轻瘫24例.河北中医,2003,25(10):738-739
[11]田宝平,胡滨.中医辨证治疗糖尿病性胃轻瘫48例.辽宁中医杂志,2004:31(9):725—726.
[12]高志扬.糖尿病性胃轻瘫辨治心法.四川中医,2003,21(8):18-19
[13]王新歧.赵进喜治疗糖尿病性胃轻瘫经验.浙江中医杂志,2005,7:280-- 281
[14]唐廷汉.半夏泻心汤治疗糖尿病胃轻瘫5O例.四川中医,2001,19(9):35.
[15]邹世昌.乌梅丸加减治疗糖尿病性胃轻瘫40例.中国中西医结合杂志,2002,22(2):150—151.
[16]郑晓军,戴一娜.升阳益胃汤治疗糖尿病胃轻瘫48例.四川中医,2001,19(7):29—30.
[17]衡先培,黄青松.胜红丸治疗糖尿病性胃轻瘫临床研究.安徽中医学院学报,2001:20(2):13一14.
[18]邵丽黎.四逆健脾导滞汤治疗糖尿病性胃轻瘫30例[J].四川中医,2003,21(6) :26—27.
[19]李翠萍.健脾消滞汤治疗糖尿病胃轻瘫疗效观察[J].广西中医药,2003,26(5):30.
[20]张惠珍.健脾益胃汤治疗糖尿病胃轻瘫38例[J].新疆中医药,1999:17(4):24—25.
[21]冯丽,陈东旭.疏肝养胃汤治疗糖尿病性胃轻瘫印例[J].河北中医,2000:22(10):758.
[22]宋秀江,田德禄,李志红等.益气通降方治疗糖尿病胃轻瘫的临床研究[J].中医药学刊,2003:21(2):273—275.
[23]沈璐,杨明丽,李群等.糖胃康治疗糖尿病胃轻瘫48例.陕西中医,2005:26(9):905—906.
[24]何百科.葛银四磨汤治疗糖尿病性胃轻瘫104例[J].陕西中医函授,2001:19(1):30.
[25]王玲.针刺治疗糖尿病胃轻瘫35例.新中医,2003,35(7):50一51.
[26]成秀梅,姬承武,孙灵娇.辨证针刺治疗糖尿病胃轻瘫36例.中国针灸,2003.23(9)525.
[27]赵红,张轶.针刺治疗糖尿病性胃轻瘫34例临床观察。中国针灸2004,24(3)167一168.
[28]朱红梅.壮医药线点灸配合壮药治疗糖尿病胃轻瘫临床观察[J].四川中医,2002,20(10):72—74
[29]蔡敬宙,潘锦瑶.耳穴贴压治疗糖尿病胃轻瘫疗效观察.辽宁中医杂志,2002,29(6):358
[30] Jebbink HJA.Braenboer BakkermansIMA etal,Diabetologia 1993,36:948-954
[31] Russell Y,Ridha A Lewea'nee,C.Gastrointestival tract compications of diabetics.Srchlntern Med,1984,144:1251.
[32]李皓旭,秦晓民,鲁彦,等.糖尿病胃轻瘫发病机制[J].胃肠病和肝病学杂志,2003,12(1):88—90.
[33] Chandrasekharan B。Srinivasan S.Diabetes and the en.teric nervous system [J].Neurogastroenterol Motil,2007,19(12):951—960
[34] Kawaglshi T , Nishizawa Y , Okuno Y , et a1.Efect ofeisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neumpathy[J].Am J Gastroenterol,1993,88(6):933—938.
[35]陈兴国,郭继强,陈新军,等.糖尿病胃轻瘫患者血清胃泌素升高[J].临床检验杂志,2005,23(5):372
[36]陈建,李君曼。李学会,等.糖尿病胃轻瘫患者的胃排空迟缓与血浆胃肠激素变化相关性探讨.山东医药,1997。37(6):9-10
[37]吴波,郑长青,林连捷,等.糖尿病性胃肠病变患者血浆P物质和胃动素的水平及意义[J].世界华人消化杂志,2003,1l(3):367—368.
[38]王雁,张彤彦,张建忠,等.西沙必利对糖尿病胃肠运动功能障碍的影响[J].基础医学与临床,1999,19(6):516—521.
[39] Rayner CK,Su YC,Doran SM,et a1.The stimulation ofantral motility by erythromycin is advenuated by hyperglycemia[J].Am J Gastroenterol,2000,95(9):2 233—2 241.
[40]张亚萍,张宽学,罗金燕.糖尿病大鼠胃肠道CaM间质细胞结构变化研究[J].中华内科学杂志,2002,41(5):310.
[41]张盛忠,卢志达,洪明理,等.20例糖尿病的胃粘膜微血管超微结构观察[J].微循环学杂志,2000,10(2):10—12.
[42]孙子林,刘乃丰,孙桂菊,等.糖尿病小鼠血清糖基化终产物水平增高[J].中国糖尿病杂志,2000,8(5):315.
[43]张春芳,胡洁,赵文.2型糖尿病患者并幽门螺杆菌感染临床分析.临床内科杂27志,200l,18(5):375—376
[44]赵丽娟.2型糖尿病与幽门螺杆菌感染.北京医学,20O2,24(1):44
[45] Guvener N , Akcan Y , Paksoy I , et a1.Helicobacter pylori associated gastric pathology in patients with type IIdiabetes mellitus and its rdatiomhip with gastric emptying : the Ankara stuay[J].Exp Clin Endoerinol Diabe.tes,l999,107(3):172—176.
[46]张亚萍,高革,张宽学,等.糖尿病胃肠功能紊乱模型肠道超微结构变化的研究[J].临床消化病杂志,2002,14(4):150—152.
[47] Lust man PJ,An.derson RJ,Freedland KE,et a1.Depression and poor glycemic controla metal ana]ytic review of the literature.Diabetes Care,2000,23934—942.
[48]杜章辉.胃复安的不良反应.中华临床医学研究杂志,2005,11(10):1432—1433
[49] David S,Mark K,Vasti B.Domperidone in the management of symp toms of diabetic gastroparesis : eficacy , tolerability , and quality of lifeoutcomes in a muhicenter controlled tria1.Clinical Therapeutics,1998,20(3):438—453
[50]王雁,张彤彦,张建忠,等.西沙必利对糖尿病胃肠运动功能障碍的影响.基础医学与临床,1999,19:516—521.
[51]陈世耀,王吉耀.莫沙必利治疗功能性消化不良的随机双盲对照研究.中华流行病学杂志,2004,25(2):165—168.
[52] Lu G,Sarr MG。Szurszeweki JH.Efect of motilin and Eryth—romyeinon calcium-activated potassium channels in rabbitcolonic myocytes. Gastroenterology,1998,114:748—754
[53]周琳,高方,薛耀明,等.依帕司他对糖尿病性胃轻瘫和自主神经病变的影响.中国新药与临床杂志,2007,26(2):134—137.
[54] Dina E,Rajkamal J,Nell K.Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.Gstrointestinal Endoscopy ,2002,7(55):920—923
[55] Ehsan J , Denis O , Emil N , et a1.Implantable neural electrical stimulator for external control of gastrointestinal motility.Medical Engineering& Physics ,2007.29:238—252.
[56]陆英杰,连至成.糖尿病胃轻瘫治疗现状,实用糖尿病杂志.2005:1(6):49—51.
[57]赵衍斌,王嫒,严颖.糖尿病胃轻瘫的研究进展.辽宁医学杂志.2004:18(4):210—211.